百奥赛图科创板IPO背后:专职研发人员骤降至5人、募资额缩水

北京商报官方账号
Jul 24

百奥赛图(北京)医药科技股份有限公司(以下简称“百奥赛图”)正在闯关科创板IPO,目前,百奥赛图披露了二轮回复意见并更新了招股书。根据公司最新披露的二轮回复意见,公司专职研发人员数量持续缩减,由2022年底的58人下降至2024年底的5人。此外,与2023年披露的最初的招股书相比,公司募资额出现缩水,由18.93亿元下降至11.85亿元。专职研发人员数量下降招股书显示,百奥赛图是一家临床前CRO...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10